TCM
TECH icon

Teza Capital Management’s Bio-Techne TECH Stock Holding History

Teza Capital Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-8,313
Closed -$689K – 706
2022
Q4 		$689K Buy
+8,313
New +$660K 0.13% 256
2021
Q4 		– Sell
-3,060
Closed -$371K – 539
2021
Q3 		$371K Buy
+3,060
New +$372K 0.18% 177

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Teza Capital Management's TECH Position: Q1 2023 in Review

Teza Capital Management sold out of Bio-Techne (TECH) in Q1 2023, closing a stake of 8,313 shares — an estimated $689K sold.

Teza Capital Management first reported a position in TECH in Q3 2021 and held it in 2 quarters. The position peaked at $689K in Q4 2022. 550 funds tracked by Wall St. Rank hold TECH as of Q1 2023.

  • Teza Capital Management reported no remaining Bio-Techne position as of Q1 2023 after selling out during the quarter.
  • Teza Capital Management sold 8,313 Bio-Techne shares in Q1 2023, an estimated $689K.
  • Teza Capital Management first reported a position in Bio-Techne in Q3 2021 and held it in 2 quarters.
  • Teza Capital Management's Bio-Techne position peaked at $689K in Q4 2022.
  • 550 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2023.

Based on Teza Capital Management's 13F filing for Q1 2023, filed 15 May 2023.